Resumen

Non-steroidal-anti-inflammatory drugs (NSAIDs) make a heterogenous pharmaco-therapeutic class of drugs among the most used drugs worldwide with various indications, modes of administration and increasing automedication. NSAIDs can cause acute liver injury with variable severity. The recent identification of genetic markers might facilitate the diagnosis and the prediction of hepatotoxicity risk.

Palabras clave: Non-steroidal-anti-inflammatory drugs NSAID hepatotoxicity drug-induced hepatitis pharmacogenetics.

2018-08-20   |   107 visitas   |   Evalua este artículo 0 valoraciones

Vol. 17 Núm.2. Marzo-Abril 2018 Pags. 187-191 Ann Hepatol 2018; 17(2)